Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,750 | 28,921 | 34,475 | 32,736 | 23,646 |
| Marketable Securities | 66,020 | 63,601 | 62,553 | 13,418 | 26,232 |
| Receivables | 0 | 6,582 | 4,335 | 2,689 | 0 |
| Other current assets | 7,130 | 536 | -16,354 | 359 | 2,168 |
| TOTAL | $92,900 | $99,640 | $85,009 | $49,202 | $52,046 |
| Non-Current Assets | |||||
| PPE Net | 33,010 | 32,712 | 34,297 | 27,871 | 27,686 |
| Investments And Advances | 30,840 | 35,883 | 18,170 | 14,742 | 11,280 |
| Other Non-Current Assets | 150 | 145 | 100 | 1,996 | 3,224 |
| TOTAL | $64,000 | $68,740 | $52,567 | $44,609 | $42,190 |
| Total Assets | $156,910 | $168,380 | $137,581 | $93,811 | $94,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 91 |
| Accounts payable and accrued liabilities | 5,550 | 4,663 | 2,170 | 6,290 | 4,971 |
| Accrued Expenses | 0 | 0 | 2,170 | 0 | 9,752 |
| Other current liabilities | 2,730 | 4,181 | 4,100 | 3,167 | 0 |
| TOTAL | $9,400 | $10,687 | $12,048 | $12,948 | $17,866 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,600 | 1,674 | 1,740 | 1,826 | 1,909 |
| aiOther Non-Current Liabilities | 280 | 242 | 180 | 103 | 0 |
| TOTAL | $16,260 | $18,794 | $18,590 | $13,007 | $9,299 |
| Total Liabilities | $25,680 | $29,481 | $30,650 | $25,955 | $27,165 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 20 | 21 | 19 |
| Retained earnings | -177,230 | -168,607 | -157,020 | -124,605 | -101,098 |
| Other shareholders' equity | -140 | -632 | -809 | -1,154 | -763 |
| TOTAL | $131,220 | $138,899 | $106,931 | $67,856 | $67,071 |
| Total Liabilities And Equity | $156,900 | $168,380 | $137,581 | $93,811 | $94,236 |